Form D · Biotechnology
Neurelis, Inc.
San Diego, CA · CIK 0001481632
Offering snapshot reported Mar 8, 2021 · SEC filing
- Reported sold
- $115M Offering amount: $120M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2021 | Initial | $114,759,923 | No comparison | 9 | SEC filing |
| Oct 16, 2020 | Amendment | $42,098,007 | $26,750,006vs Feb 3, 2020 | 26 | SEC filing |
| Feb 3, 2020 | Initial | $15,348,001 | No comparison | 25 | SEC filing |
| Nov 20, 2018 | Initial | $40,500,000 | No comparison | 15 | SEC filing |
| Aug 24, 2018 | Initial | $5,200,000 | No comparison | 11 | SEC filing |
| Dec 7, 2017 | Amendment | $15,000,000 | $5,000,000vs Jan 6, 2017 | 2 | SEC filing |
| Jan 6, 2017 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
| Jul 16, 2015 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Sep 30, 2011 | Initial | $1,083,950 | No comparison | 14 | SEC filing |
| Feb 3, 2010 | Initial | $1,700,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.4M
- Finders' fees
- $0
- Form D file number
- 021-391462
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aquilo Partners, L.P. | 114909 |
Source: Form D, filed Mar 8, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Priyanka Belawat | Director |
| Stephen Cartt | Director |
| Craig C. Chambliss | Director, Executive |
| Cam L. Garner | Director |
| David A. Gonyer | Director |
| David F. Hale | Director |
| William R. La Rue | Director |
| Kevin Li | Director |
| Huaizheng Peng | Director |
| George Stuart | Executive |
| Yong Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3430 Carmel Mountain Road Suite 300
San Diego, CA, 92121
San Diego, CA, 92121